IMM 1.61% 31.5¢ immutep limited

us fda preind meeting request submitted for cv, page-11

  1. 5,813 Posts.
    thats might be a very interesting scenario for PPR.

    PPR get the FDA go ahead and PPR itself could be snatched off the market very fast.

    I think PPR is already under very close survilence from some big players in the BIO sector.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.